Global Bladder Cancer Drugs Market Growth (Status and Outlook) 2022-2028
- LP 4883073
- 88 Pages
- March 2022
- Pharmaceuticals
The United States Bladder Cancer Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Bladder Cancer Drugs market, reaching US$ million by the year 2028. As for the Europe Bladder Cancer Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Bladder Cancer Drugs players cover Bristol-Myers Squibb, AstraZeneca, Pfizer, and Celgene Corporation, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Bladder Cancer Drugs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Non-Muscle-Invasive Bladder Cancer
Muscle-Invasive Bladder Cancer
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Low-Grade Tumors
High-Grade Tumors
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Bristol-Myers Squibb
AstraZeneca
Pfizer
Celgene Corporation
Eli Lilly
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bladder Cancer Drugs Market Size 2017-2028
2.1.2 Bladder Cancer Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Bladder Cancer Drugs Segment by Type
2.2.1 Non-Muscle-Invasive Bladder Cancer
2.2.2 Muscle-Invasive Bladder Cancer
2.3 Bladder Cancer Drugs Market Size by Type
2.3.1 Bladder Cancer Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Bladder Cancer Drugs Market Size Market Share by Type (2017-2022)
2.4 Bladder Cancer Drugs Segment by Application
2.4.1 Low-Grade Tumors
2.4.2 High-Grade Tumors
2.5 Bladder Cancer Drugs Market Size by Application
2.5.1 Bladder Cancer Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Bladder Cancer Drugs Market Size Market Share by Application (2017-2022)
3 Bladder Cancer Drugs Market Size by Player
3.1 Bladder Cancer Drugs Market Size Market Share by Players
3.1.1 Global Bladder Cancer Drugs Revenue by Players (2020-2022)
3.1.2 Global Bladder Cancer Drugs Revenue Market Share by Players (2020-2022)
3.2 Global Bladder Cancer Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Bladder Cancer Drugs by Regions
4.1 Bladder Cancer Drugs Market Size by Regions (2017-2022)
4.2 Americas Bladder Cancer Drugs Market Size Growth (2017-2022)
4.3 APAC Bladder Cancer Drugs Market Size Growth (2017-2022)
4.4 Europe Bladder Cancer Drugs Market Size Growth (2017-2022)
4.5 Middle East & Africa Bladder Cancer Drugs Market Size Growth (2017-2022)
5 Americas
5.1 Americas Bladder Cancer Drugs Market Size by Country (2017-2022)
5.2 Americas Bladder Cancer Drugs Market Size by Type (2017-2022)
5.3 Americas Bladder Cancer Drugs Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bladder Cancer Drugs Market Size by Region (2017-2022)
6.2 APAC Bladder Cancer Drugs Market Size by Type (2017-2022)
6.3 APAC Bladder Cancer Drugs Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Bladder Cancer Drugs by Country (2017-2022)
7.2 Europe Bladder Cancer Drugs Market Size by Type (2017-2022)
7.3 Europe Bladder Cancer Drugs Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bladder Cancer Drugs by Region (2017-2022)
8.2 Middle East & Africa Bladder Cancer Drugs Market Size by Type (2017-2022)
8.3 Middle East & Africa Bladder Cancer Drugs Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Bladder Cancer Drugs Market Forecast
10.1 Global Bladder Cancer Drugs Forecast by Regions (2023-2028)
10.1.1 Global Bladder Cancer Drugs Forecast by Regions (2023-2028)
10.1.2 Americas Bladder Cancer Drugs Forecast
10.1.3 APAC Bladder Cancer Drugs Forecast
10.1.4 Europe Bladder Cancer Drugs Forecast
10.1.5 Middle East & Africa Bladder Cancer Drugs Forecast
10.2 Americas Bladder Cancer Drugs Forecast by Country (2023-2028)
10.2.1 United States Bladder Cancer Drugs Market Forecast
10.2.2 Canada Bladder Cancer Drugs Market Forecast
10.2.3 Mexico Bladder Cancer Drugs Market Forecast
10.2.4 Brazil Bladder Cancer Drugs Market Forecast
10.3 APAC Bladder Cancer Drugs Forecast by Region (2023-2028)
10.3.1 China Bladder Cancer Drugs Market Forecast
10.3.2 Japan Bladder Cancer Drugs Market Forecast
10.3.3 Korea Bladder Cancer Drugs Market Forecast
10.3.4 Southeast Asia Bladder Cancer Drugs Market Forecast
10.3.5 India Bladder Cancer Drugs Market Forecast
10.3.6 Australia Bladder Cancer Drugs Market Forecast
10.4 Europe Bladder Cancer Drugs Forecast by Country (2023-2028)
10.4.1 Germany Bladder Cancer Drugs Market Forecast
10.4.2 France Bladder Cancer Drugs Market Forecast
10.4.3 UK Bladder Cancer Drugs Market Forecast
10.4.4 Italy Bladder Cancer Drugs Market Forecast
10.4.5 Russia Bladder Cancer Drugs Market Forecast
10.5 Middle East & Africa Bladder Cancer Drugs Forecast by Region (2023-2028)
10.5.1 Egypt Bladder Cancer Drugs Market Forecast
10.5.2 South Africa Bladder Cancer Drugs Market Forecast
10.5.3 Israel Bladder Cancer Drugs Market Forecast
10.5.4 Turkey Bladder Cancer Drugs Market Forecast
10.5.5 GCC Countries Bladder Cancer Drugs Market Forecast
10.6 Global Bladder Cancer Drugs Forecast by Type (2023-2028)
10.7 Global Bladder Cancer Drugs Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Information
11.1.2 Bristol-Myers Squibb Bladder Cancer Drugs Product Offered
11.1.3 Bristol-Myers Squibb Bladder Cancer Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Bristol-Myers Squibb Main Business Overview
11.1.5 Bristol-Myers Squibb Latest Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Information
11.2.2 AstraZeneca Bladder Cancer Drugs Product Offered
11.2.3 AstraZeneca Bladder Cancer Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 AstraZeneca Main Business Overview
11.2.5 AstraZeneca Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Bladder Cancer Drugs Product Offered
11.3.3 Pfizer Bladder Cancer Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Celgene Corporation
11.4.1 Celgene Corporation Company Information
11.4.2 Celgene Corporation Bladder Cancer Drugs Product Offered
11.4.3 Celgene Corporation Bladder Cancer Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Celgene Corporation Main Business Overview
11.4.5 Celgene Corporation Latest Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Information
11.5.2 Eli Lilly Bladder Cancer Drugs Product Offered
11.5.3 Eli Lilly Bladder Cancer Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Eli Lilly Main Business Overview
11.5.5 Eli Lilly Latest Developments
12 Research Findings and Conclusion
Table 1. Bladder Cancer Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Non-Muscle-Invasive Bladder Cancer
Table 3. Major Players of Muscle-Invasive Bladder Cancer
Table 4. Bladder Cancer Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Bladder Cancer Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Bladder Cancer Drugs Market Size Market Share by Type (2017-2022)
Table 7. Bladder Cancer Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Bladder Cancer Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Bladder Cancer Drugs Market Size Market Share by Application (2017-2022)
Table 10. Global Bladder Cancer Drugs Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Bladder Cancer Drugs Revenue Market Share by Player (2020-2022)
Table 12. Bladder Cancer Drugs Key Players Head office and Products Offered
Table 13. Bladder Cancer Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Bladder Cancer Drugs Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Bladder Cancer Drugs Market Size Market Share by Regions (2017-2022)
Table 18. Americas Bladder Cancer Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Bladder Cancer Drugs Market Size Market Share by Country (2017-2022)
Table 20. Americas Bladder Cancer Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Bladder Cancer Drugs Market Size Market Share by Type (2017-2022)
Table 22. Americas Bladder Cancer Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Bladder Cancer Drugs Market Size Market Share by Application (2017-2022)
Table 24. APAC Bladder Cancer Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Bladder Cancer Drugs Market Size Market Share by Region (2017-2022)
Table 26. APAC Bladder Cancer Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Bladder Cancer Drugs Market Size Market Share by Type (2017-2022)
Table 28. APAC Bladder Cancer Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Bladder Cancer Drugs Market Size Market Share by Application (2017-2022)
Table 30. Europe Bladder Cancer Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Bladder Cancer Drugs Market Size Market Share by Country (2017-2022)
Table 32. Europe Bladder Cancer Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Bladder Cancer Drugs Market Size Market Share by Type (2017-2022)
Table 34. Europe Bladder Cancer Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Bladder Cancer Drugs Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Bladder Cancer Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Bladder Cancer Drugs Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Bladder Cancer Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Bladder Cancer Drugs Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Bladder Cancer Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Bladder Cancer Drugs Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Bladder Cancer Drugs
Table 43. Key Market Challenges & Risks of Bladder Cancer Drugs
Table 44. Key Industry Trends of Bladder Cancer Drugs
Table 45. Global Bladder Cancer Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Bladder Cancer Drugs Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Bladder Cancer Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Bladder Cancer Drugs Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Bladder Cancer Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Bladder Cancer Drugs Market Size Market Share Forecast by Application (2023-2028)
Table 51. Bristol-Myers Squibb Details, Company Type, Bladder Cancer Drugs Area Served and Its Competitors
Table 52. Bristol-Myers Squibb Bladder Cancer Drugs Product Offered
Table 53. Bristol-Myers Squibb Bladder Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Bristol-Myers Squibb Main Business
Table 55. Bristol-Myers Squibb Latest Developments
Table 56. AstraZeneca Details, Company Type, Bladder Cancer Drugs Area Served and Its Competitors
Table 57. AstraZeneca Bladder Cancer Drugs Product Offered
Table 58. AstraZeneca Main Business
Table 59. AstraZeneca Bladder Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. AstraZeneca Latest Developments
Table 61. Pfizer Details, Company Type, Bladder Cancer Drugs Area Served and Its Competitors
Table 62. Pfizer Bladder Cancer Drugs Product Offered
Table 63. Pfizer Main Business
Table 64. Pfizer Bladder Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Pfizer Latest Developments
Table 66. Celgene Corporation Details, Company Type, Bladder Cancer Drugs Area Served and Its Competitors
Table 67. Celgene Corporation Bladder Cancer Drugs Product Offered
Table 68. Celgene Corporation Main Business
Table 69. Celgene Corporation Bladder Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Celgene Corporation Latest Developments
Table 71. Eli Lilly Details, Company Type, Bladder Cancer Drugs Area Served and Its Competitors
Table 72. Eli Lilly Bladder Cancer Drugs Product Offered
Table 73. Eli Lilly Main Business
Table 74. Eli Lilly Bladder Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Eli Lilly Latest Developments
List of Figures
Figure 1. Bladder Cancer Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Bladder Cancer Drugs Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Bladder Cancer Drugs Market Size Market Share by Type in 2021
Figure 7. Bladder Cancer Drugs in Low-Grade Tumors
Figure 8. Global Bladder Cancer Drugs Market: Low-Grade Tumors (2017-2022) & ($ Millions)
Figure 9. Bladder Cancer Drugs in High-Grade Tumors
Figure 10. Global Bladder Cancer Drugs Market: High-Grade Tumors (2017-2022) & ($ Millions)
Figure 11. Global Bladder Cancer Drugs Market Size Market Share by Application in 2021
Figure 12. Global Bladder Cancer Drugs Revenue Market Share by Player in 2021
Figure 13. Global Bladder Cancer Drugs Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Bladder Cancer Drugs Market Size 2017-2022 ($ Millions)
Figure 15. APAC Bladder Cancer Drugs Market Size 2017-2022 ($ Millions)
Figure 16. Europe Bladder Cancer Drugs Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Bladder Cancer Drugs Market Size 2017-2022 ($ Millions)
Figure 18. Americas Bladder Cancer Drugs Value Market Share by Country in 2021
Figure 19. Americas Bladder Cancer Drugs Consumption Market Share by Type in 2021
Figure 20. Americas Bladder Cancer Drugs Market Size Market Share by Application in 2021
Figure 21. United States Bladder Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Bladder Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Bladder Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Bladder Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Bladder Cancer Drugs Market Size Market Share by Region in 2021
Figure 26. APAC Bladder Cancer Drugs Market Size Market Share by Application in 2021
Figure 27. China Bladder Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Bladder Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Bladder Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Bladder Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Bladder Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Bladder Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Bladder Cancer Drugs Market Size Market Share by Country in 2021
Figure 34. Europe Bladder Cancer Drugs Market Size Market Share by Type in 2021
Figure 35. Europe Bladder Cancer Drugs Market Size Market Share by Application in 2021
Figure 36. Germany Bladder Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Bladder Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Bladder Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Bladder Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Bladder Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Bladder Cancer Drugs Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Bladder Cancer Drugs Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Bladder Cancer Drugs Market Size Market Share by Application in 2021
Figure 44. Egypt Bladder Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Bladder Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Bladder Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Bladder Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Bladder Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Bladder Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 50. APAC Bladder Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 51. Europe Bladder Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Bladder Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 53. United States Bladder Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 54. Canada Bladder Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Bladder Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Bladder Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 57. China Bladder Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 58. Japan Bladder Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 59. Korea Bladder Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Bladder Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 61. India Bladder Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 62. Australia Bladder Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 63. Germany Bladder Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 64. France Bladder Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 65. UK Bladder Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 66. Italy Bladder Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 67. Russia Bladder Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 68. Spain Bladder Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Bladder Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Bladder Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 71. Israel Bladder Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Bladder Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Bladder Cancer Drugs Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
